CLINICAL TRIALS PROFILE FOR DORZAGLIATIN
✉ Email this page to a colleague
Clinical Trials for Dorzagliatin
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT03790787 ↗ | Drug Interaction Study Between Dorzagliatin and Empagliflozin | Completed | Hua Medicine Limited | Phase 1 | This is a Phase 1, open-label, sequential, multiple-dose, drug interaction study of glucokinase activator dorzagliatin and empagliflozin in subjects with T2DM. Pharmacokinetics and pharmacodynamics when dorzagliatin and empagliflozin given alone and in combination will be studied. |
NCT03790839 ↗ | Drug Interaction Study Between Dorzagliatin and Sitagliptin | Completed | Hua Medicine Limited | Phase 1 | This is a Phase 1, open-label, sequential, multiple-dose, drug interaction study of glucokinase activator dorzagliatin and sitagliptin in subjects with T2DM. Pharmacokinetics and pharmacodynamics when dorzagliatin and sitagliptin given alone and in combination will be studied. |
NCT04080596 ↗ | DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin | Completed | Hua Medicine Limited | Phase 1 | The purpose of this study is to investigate the impact of itraconzaole on the pharmacokinetics of Dorzagliatin. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Dorzagliatin
Condition Name
Clinical Trial Locations for Dorzagliatin
Trials by Country
Clinical Trial Progress for Dorzagliatin
Clinical Trial Phase
Clinical Trial Sponsors for Dorzagliatin
Sponsor Name